Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRR1 | P24046 | 2/20 | 0.48 |
| ▸ | GGT1 | P19440 | 1/20 | 0.44 |
| ▸ | MME | P08473 | 1/20 | 0.38 |
| ▸ | CPB2 | Q96IY4 | 4/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | CPB1 | P15086 | 1/20 | 0.34 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.33 |
| ▸ | NAALAD2 | Q9Y3Q0 | 2/20 | 0.33 |
| ▸ | ENPEP | Q07075 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL164972 | 0.98 | — | — | |
| SCHEMBL15453401 | 0.98 | — | — | |
| SCHEMBL601790 | 0.98 | — | — | |
| SCHEMBL29941227 | 0.95 | GABRR1 (0.48) | GABRR1GGT1MMECPB2ALDH1A1 | |
| Hydrochloric Acid SCHEMBL29390190 | 0.95 | GABRR1 (0.48) | GABRR1GGT1MMECPB2ALDH1A1 | |
| Magnesium SCHEMBL30922377 | 0.93 | GABRR1 (0.46) | GABRR1GGT1MMECPB2ALDH1A1 | |
| SCHEMBL30922373 | 0.93 | GABRR1 (0.46) | GABRR1GGT1MMECPB2ALDH1A1 | |
| SCHEMBL30922372 | 0.93 | GABRR1 (0.46) | GABRR1GGT1MMECPB2ALDH1A1 | |
| SCHEMBL28523225 | 0.86 | GABRR1 (0.41) | GABRR1GGT1MMECPB2ALDH1A1 | |
| SCHEMBL28523224 | 0.86 | GABRR1 (0.41) | GABRR1GGT1MMECPB2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117756159-A | Method for preparing layered calcium sulfate by using phosphogypsum | 贵州省材料产业技术研究院 | 2024-03-26 | — | — | CN | claimed |
| CN-117756159-A | Method for preparing layered calcium sulfate by using phosphogypsum | 贵州省材料产业技术研究院 | 2024-03-26 | — | — | CN | disclosed |
| CN-115058000-A | Flame-retardant polyester diol and flame-retardant waterborne polyurethane | 江苏景宏新材料科技有限公司 | 2022-09-16 | — | — | CN | disclosed |
| US-20050058619-A1 | Polyether-modified polymers as leather auxiliaries | LANXESS DEUTSCHLAND GMBH (DE) | 2005-03-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050058619-A1 | Polyether-modified polymers as leather auxiliaries | PUF60, B2M, CBR3 | GABRR1 2666/4885GGT1 2616/4885MME 1660/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.